Researchers are already testing triple-agonist drugs, such as retatrutide, which target GLP-1, GIP and glucagon receptors
In related news, Pfizer recently announced that it was dropping development work on a weight loss drug while continuing work on another
Dietary guidance is typically part of your personalized weight loss plan
Choosing the right product often comes down to your unique needs and the expertise of your injector
But other early research suggests that semaglutide and other GLP-1 medications could interact with the brains reward system in a way that helps modulate cravings, whether for food, nicotine, alcohol or other drugs
Scores of 1 or 2 indicate less diversity than the defined normobiotic reference population